Farm families that consume milk, eggs and beef they raise themselves face an increased risk of cancer if their fields were ...
Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...